Navigate Up
Launch the Developer Dashboard
The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS clinical trials networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
Read more about our mission​ ​​​​​​


​Get Involved in HIV/AIDS Clinical Trials

Learn more about participating in a clinical research study or engaging your community in clinical trials research.

Calandar Image

HANC Calendar

​Check for scientific conferences, network meetings, community events, training dates, etc. 

Training Resources

​View a variety of training resources including the online HIV Research Counseling and Testing (HRCT) curriculum, HSP and GCP training.

Lab Resources

​Find info for labs such as procedures and SOPs.


ACTG/IMPAACT Lab Manual Link


​Legacy Project

Learn how HANC is working to increase participation of underrepresented populations in HIV clinical trials.

HANC is supported through a cooperative
agreement with the National Institute of Allergy
and Infectious Disease (NIAID)

Find us, follow us, friend us:

   Link to FHCRC

Announ​cem​ents ​

IMPAACT 2016: Evaluating a Group-Based Intervention to Improve Mental Health and ART Adherence in HIV-Infected Adolescents in Low Resource Settings

​April 26, 2019 @ 7AM PST

The HANC-facilitated Youth Prevention Working Group (YPRWG) invites you to a webinar on IMPAACT 2016 featuring study Co-chairs Dr. Dorothy Dow and Dr. Geri Donenberg.​ IMPAACT 2016 builds on the Kigali Imbereheza Project funded by NICHD to examine the effects of peer-delivered trauma-informed cognitive behavioral therapy on mental health outcomes and ART adherence for adolescents living with HIV. Regis​ter here.

HIV Genetic Sequencing (HGS) Webinar Series

HIV genetic sequencing (HGS) is a powerful tool that is helping us to better understand HIV, but it also raises some critical ethical concerns.

Part 1: Without Our Consent: Centering People Living with HIV in HIV Genetic Sequencing

March 27, 2019 @ 1PM PST

Learn more about HGS and how you can advocate for the meaningful and ethical use of this technology in part 1 of this four-part webinar series.View the recording here​.

Part 2: These Trees Cast No Shade: Understanding HIV Phylogen​etics Research

April 18, 2019 @ 10AM PST

In the second webinar in the series, Dr. Carl Dieffenbach will explain phylogenetics, how it is being used in HIV research, and how the communities most impacted by HIV are being prioritized in this research. Venita Ray will then share recommendations for conducting this research ethically​. View the recording here​.

Part 3: Understanding Molecular HIV Surveillance

April 25, 2019 @ 11AM PST

In Part 3 of this series, we turn our attention to the public health use of HIV genetic sequencing known as molecular HIV surveillance (MHS). Dr. Eugene McCray will explain MHS from the perspective of the Centers for Disease Control and Prevention. We will then hear from Naina Khanna (Positive Women’s Network-USA) who will discuss ethical and social justice considerations for MHS​. Register here.

Part 4: Community Town Hall: HIV Genetic Sequencing

May 15, 2019 @ 1PM PST

Join us for the closing webinar in this four-part series. Registration forthcoming.

Digg Delicious Facebook Newsvine Reddit StumbleUpon Twitter Email Link




© HIV/AIDS Network Coordination